www.taro.com

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

News Releases



Receive E-mail AlertsE-mail Alert Icon Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Date Title  
Toggle Summary Taro Provides Results for Quarter Ended June 30, 2021
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jul. 27, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) today provided unaudited financial results for the quarter ended June 30, 2021 . Quarter ended June 30, 2021 Highlights - compared to Quarter ended June 30, 2020 Net sales increased $29.5
Printer Friendly Version
Toggle Summary Taro to Announce First Quarter Results on July 27, 2021
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jul. 20, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2021 , after the close of market on Tuesday, July 27, 2021 .
Printer Friendly Version
Toggle Summary Taro Announces Resignation of Chief Financial Officer
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jul. 14, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) announced today that it has accepted the resignation of its Chief Financial Officer, Daphne Huang , effective August 6, 2021 . Ms.
Printer Friendly Version
Toggle Summary Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2021
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jun. 18, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2021 , filed with the Securities and Exchange Commission (the “SEC”), is available within the Investor
Printer Friendly Version
Toggle Summary Taro Provides Results for the Year Ended March 31, 2021
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 19, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2021 . Quarter ended March 31, 2021 Highlights ─ compared to March 31, 2020 Net sales of
Printer Friendly Version
Toggle Summary Taro to Announce Full Year Results on May 19, 2021
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 12, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for year ended March 31, 2021 , on Wednesday, May 19, 2021 . The release will be accessible on Taro’s website at www.taro.com .
Printer Friendly Version
Toggle Summary Taro Provides Results for December 31, 2020
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 27, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2020 . Quarter ended December 31, 2020 Highlights ─ compared to December 31,
Printer Friendly Version
Toggle Summary Taro to Announce Third Quarter Results on January 27, 2021
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 20, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2020 , after the close of market on Wednesday, January 27, 2021 .
Printer Friendly Version
Toggle Summary Taro Provides Results for September 30, 2020
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 28, 2020-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and six months ended September 30, 2020 . Quarter ended September 30, 2020 Highlights ─ compared to September 30,
Printer Friendly Version
Toggle Summary Taro to Announce Second Quarter Results on October 28, 2020
Earnings Call on Thursday, October 29th at 8:00 am ET HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 21, 2020-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2020 , on Wednesday, October
Printer Friendly Version
Terms of Use
|
Privacy Statement
|
Safe Harbor Statement